THE ROLE OF III GENERATION CEPHALOSPORINS IN THE TREATMENT OF URINARY TRACT INFECTIONS

Toshpulatov To‘lqin Aliyarovich

senior lecturer at the Department of Natural Sciences of the Termiz University of Economics and Service

Boyqulov To‘rabek Temirovich

teacher of the Department of Natural Sciences of Termiz University of Economics and Service

Keywords: cystitis, lower urinary tract infection, uropathogens, cephalosporins, cefixime, bacteriuria, clinical indications.


Abstract

Treatment of lower urinary tract infections, such as cystitis or asymptomatic bacteriuria, is often more difficult in practice than it appears at first glance. The choice of antibacterial drugs should be made taking into account the effectiveness, side effects, as well as their cost and availability, proven in clinical studies. Many results of epidemiological studies show a steady increase in the resistance of uropathogens to antibiotics, which, in turn, leads to an increase in the number of treatment failures and repeated forms of the disease. Fosfomycin and nitrofurans are recommended as first-line drugs, taking into account that when choosing an antibiotic, preference should be given to drugs with a low risk of selecting resistant microorganisms. According to the current clinical guidelines, it is recommended to use third-generation cephalosporins as an alternative therapy for lower urinary tract infections, including in pregnant women, allergy, lack of sensitivity of the pathogen or ineffective treatment for the first time. The article presents information on the effectiveness of third-generation cephalosporins in the treatment of lower urinary tract infections.


References

Клинические рекомендации. Цистит у женщин. 2021. (Электронный ресурс.) URL: https://cr.minzdrav.gov.ru/recomend/14_2 (2023).

Клинические рекомендации. Инфекция мочевых путей при беременности. https://cr.minzdrav.gov.ru/recomend/719_1?ysclid=libzfqd (2023).

Стратегия предупреждения распространения антимикробной резистентности в Российской Федерации на период до 2030 г. (Электронный ресурс.) URL: https://static-0. (2023).

World Health Organisation. Global action plan on antimicrobial resistance. Geneva: WHO; 2015.

Fluoroquinolone and quinolone antibiotics: PRAC recommends new restrictions on use following review of disabling and potentially long-https://www.ema.europa.eu/en/news/fluoroquinolone-quinolone-antibiotics-prac-recommends-new-restrict. (2023).

European Medicines Agency. Disabling and potentially permanent side effects lead tosuspension or restrictions of fluoroquinolone antibiotics. 2023).

Boyqulov T.T. va boshqalar. COVID-19 INFEKSIYASIDA ERKAKLAR BEPUSHTLIGI VA JINSIY ZAIFLIK. 2023, https://scholar.google.com/citations?view_op=view_citation&hl=ru&user=hJ-8kMMAAAAJ&authuser=1&citation_for_view=hJ-8kMMAAAAJ:roLk4NBRz8UC

Boyqulov T.T. va boshqalar. SIYDIK-TANOSIL TIZIMI VA COVID-19 HAQIDA BA’ZI BIR SAVOLLAR. https://scholar.google.com/citations?view_op=view_citation&hl=ru&user=hJ-8kMMAAAAJ&authuser=1&citation_for_view=hJ-8kMMAAAAJ:Se3iqnhoufwC

Boyqulov T.T. va boshqalar URUG ‘SIFATI VA QONDAGI TESTOSTERONNING VARIKOSELEKTOMIYADAN OLDIN VA KEYINGI MIQDORI O’ZGARISHI https://scholar.google.com/citations?view_op=view_citation&hl=ru&user=hJ-8kMMAAAAJ&citation_for_view=hJ-8kMMAAAAJ:kNdYIx-mwKoC